NCT02589262View on ClinicalTrials.gov

Safety, Blood Levels and Effects of AUT00206

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Schizophrenia
Interventions
DRUG

AUT00206

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors
All Listed Sponsors
lead

Autifony Therapeutics Limited

INDUSTRY

NCT02589262 - Safety, Blood Levels and Effects of AUT00206 | Biotech Hunter | Biotech Hunter